Drug intelligence / Profile preview

esat6-cfp10 + tuberculin purified protein derivative

Development stage
Unknown
Lead developer
Zhifei Longcom Biologic Pharmacy
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Administration
Intradermal
01

Overview

esat6-cfp10 + tuberculin purified protein derivative is a combination of two diagnostic reagents used for the detection of Mycobacterium tuberculosis infection. Tuberculin purified protein derivative (PPD) is a mixture of proteins derived from M. tuberculosis, traditionally used in the Mantoux skin test to detect latent or active tuberculosis infection by eliciting a delayed-type hypersensitivity (DTH) response[1][3]. ESAT6-CFP10 is a recombinant fusion protein composed of two highly immunogenic antigens, Early Secreted Antigenic Target 6 kDa (ESAT-6) and Culture Filtrate Protein 10 kDa (CFP10), which are absent in BCG vaccine strains and most non-tuberculosis mycobacteria[2][3]. This combination aims to improve specificity and sensitivity for TB diagnosis compared to PPD alone, as ESAT6-CFP10 can distinguish M. tuberculosis infection from BCG vaccination and environmental mycobacterial exposure[8][3]. Both components act as skin test reagents that stimulate T-cell mediated immune responses at the site of injection; their combined use may enhance diagnostic accuracy for TB.

Brand names
Yi KaEkear
Other names
ESAT-6-CFP10ESAT6-CFP10ESAT 6-CFP10PPDPurified Protein DerivativeRecombinant ESAT6-CFP10 fusion protein
02

Targets

γδ TCR (T-cell receptor)

Beyond the preview

Go deeper on esat6-cfp10 + tuberculin purified protein derivative.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on esat6-cfp10 + tuberculin purified protein derivative.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call